BIOMAT Database Logo BIOMAT Database Logo

High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation. 1998

S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
December 1997, Blood,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
September 2001, Blood,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Chronic graft versus host disease after allogeneic peripheral blood transplantation.
March 2003, Haematologica,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
January 2005, Blood,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
September 1996, Blood,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
April 2005, American journal of hematology,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Allogeneic peripheral blood stem cell transplantation significantly increases risk of chronic graft-versus-host disease of lung compared with bone marrow transplantation.
December 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
April 2002, International journal of hematology,
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
[Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].
May 2009, Deutsche medizinische Wochenschrift (1946),
S Kalayoğlu-Beşişik, and T Budak-Alpdoğan, and M Nuri Yenerel, and D Sargin, and Y Tangün
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
August 1999, Blood,
Copied contents to your clipboard!